172@29@16@18!~!172@29@0@53!~!|commonstore|commonfiles|moneycontrol_header.php?cid=0&s_cid=0&radar_off=0&is_revamped_header=0&is_responsive=1&sec=PNC_FINANCIAL&priceinter=1&frommc=1!~!|commonstore|commonfiles|moneycontrol_header.php
Moneycontrol
SENSEX NIFTY
you are here:

AstraZeneca Pharma Ltd.

BSE: 506820 | NSE: ASTRAZEN |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE203A01020 | SECTOR: Pharmaceuticals

BSE Live

Aug 07, 16:00
3331.80 -7.35 (-0.22%)
Volume
AVERAGE VOLUME
5-Day
2,606
10-Day
2,540
30-Day
4,970
1,563
  • Prev. Close

    3339.15

  • Open Price

    3349.15

  • Bid Price (Qty.)

    3331.80 (18)

  • Offer Price (Qty.)

    3331.80 (3)

NSE Live

Aug 07, 15:58
3332.80 -8.50 (-0.25%)
Volume
AVERAGE VOLUME
5-Day
56,053
10-Day
45,534
30-Day
68,300
23,134
  • Prev. Close

    3341.30

  • Open Price

    3357.40

  • Bid Price (Qty.)

    3332.80 (73)

  • Offer Price (Qty.)

    0.00 (0)

Financials

2019 2018 2017 2016 2015
Profit & Loss account of AstraZeneca Pharma (in Rs. Cr.) Mar 20 Mar 19 Mar 18 Mar 17 Mar 16  
  12 mths 12 mths 12 mths 12 mths 12 mths  
INCOME  
Revenue From Operations [Gross] 831.81 728.24 557.60 535.40 532.67  
Less: Excise/Sevice Tax/Other Levies 0.00 0.00 0.99 4.95 6.21  
Revenue From Operations [Net] 831.81 728.24 556.61 530.45 526.46  
Total Operating Revenues 831.81 728.29 571.00 543.71 563.73  
Other Income 12.99 16.29 12.25 14.39 6.77  
Total Revenue 844.80 744.58 583.25 558.10 570.50  
EXPENSES  
Cost Of Materials Consumed 70.21 62.67 27.88 14.01 34.76  
Operating And Direct Expenses 0.00 0.00 0.00 0.00 0.00  
Changes In Inventories Of FG,WIP And Stock-In Trade -39.21 -1.38 -51.00 17.98 5.42  
Employee Benefit Expenses 216.70 197.40 153.53 162.04 169.35  
Finance Costs 1.14 0.00 0.00 0.00 0.00  
Depreciation And Amortisation Expenses 18.58 14.92 14.74 15.83 17.43  
Other Expenses 189.18 228.46 190.09 170.79 178.91  
Total Expenses 730.84 671.91 539.45 522.60 564.74  
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 113.96 72.67 43.80 35.50 5.76  
Exceptional Items 0.00 0.00 0.00 0.00 0.00  
Profit/Loss Before Tax 113.96 72.67 43.80 35.50 5.76  
Tax Expenses-Continued Operations  
Current Tax 41.75 16.68 9.00 8.76 0.50  
Less: MAT Credit Entitlement 0.00 0.00 0.00 0.00 0.00  
Deferred Tax 0.00 1.54 8.89 6.69 0.00  
Tax For Earlier Years 0.00 0.00 0.00 0.00 0.00  
Total Tax Expenses 41.75 18.22 17.89 15.45 0.50  
Profit/Loss After Tax And Before ExtraOrdinary Items 72.21 54.45 25.91 20.05 5.26  
Profit/Loss From Continuing Operations 72.21 54.45 25.91 20.05 5.26  
Profit/Loss For The Period 72.21 54.45 25.91 20.05 5.26  
OTHER ADDITIONAL INFORMATION  
EARNINGS PER SHARE  
Basic EPS (Rs.) 28.66 21.80 10.40 8.00 2.10  
Diluted EPS (Rs.) 28.66 21.80 10.40 8.00 2.10  
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS  
Imported Raw Materials 0.00 0.00 0.00 0.00 21.66  
Indigenous Raw Materials 0.00 0.00 0.00 0.00 13.10  
STORES, SPARES AND LOOSE TOOLS  
Imported Stores And Spares 0.00 0.00 0.00 0.00 0.00  
Indigenous Stores And Spares 0.00 0.00 0.00 0.00 2.59  
DIVIDEND AND DIVIDEND PERCENTAGE  
Equity Share Dividend 0.00 0.00 0.00 0.00 0.00  
Tax On Dividend 0.00 0.00 0.00 0.00 0.00  
Equity Dividend Rate (%) 50.00 0.00 0.00 0.00 0.00  
Source : Dion Global Solutions Limited